PortfoliosLab logoPortfoliosLab logo
IXJ vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IXJ vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Global Healthcare ETF (IXJ) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


IXJ

1D
0.39%
1M
0.34%
YTD
-5.26%
6M
-4.88%
1Y
9.30%
3Y*
4.42%
5Y*
4.02%
10Y*
7.66%

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IXJ vs. GERM - Yearly Performance Comparison


2026 (YTD)20252024
IXJ
iShares Global Healthcare ETF
-5.26%14.99%-12.26%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%

IXJ vs. GERM - Sectors Allocation Comparison


Sectors
IXJ
GERM

Healthcare

98.9%
99.3%

Consumer Defensive

0.5%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Energy

-

-

Financial Services

-

0.4%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

IXJ
98.9%
GERM
99.3%

Consumer Defensive

IXJ
0.5%
GERM

-

Basic Materials

IXJ

-

GERM

-

Communication Services

IXJ

-

GERM

-

Consumer Cyclical

IXJ

-

GERM

-

Energy

IXJ

-

GERM

-

Financial Services

IXJ

-

GERM
0.4%

Industrials

IXJ

-

GERM

-

Real Estate

IXJ

-

GERM

-

Technology

IXJ

-

GERM

-

Utilities

IXJ

-

GERM

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IXJ vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IXJ
IXJ Risk / Return Rank: 1919
Overall Rank
IXJ Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
IXJ Sortino Ratio Rank: 2020
Sortino Ratio Rank
IXJ Omega Ratio Rank: 1818
Omega Ratio Rank
IXJ Calmar Ratio Rank: 2020
Calmar Ratio Rank
IXJ Martin Ratio Rank: 1919
Martin Ratio Rank

GERM
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IXJ vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IXJGERMDifference

Sharpe ratio

Return per unit of total volatility

0.64

Sortino ratio

Return per unit of downside risk

1.06

Omega ratio

Gain probability vs. loss probability

1.12

Calmar ratio

Return relative to maximum drawdown

0.87

Martin ratio

Return relative to average drawdown

2.11

IXJ vs. GERM - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


IXJGERMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.64

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.28

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.49

Sharpe Ratio (All Time)

Calculated using the full available price history

0.42

Drawdowns

IXJ vs. GERM - Drawdown Comparison

The maximum IXJ drawdown since its inception was -40.60%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for IXJ and GERM.


Loading charts...

Drawdown Indicators


IXJGERMDifference

Max Drawdown

Largest peak-to-trough decline

-40.60%

0.00%

-40.60%

Max Drawdown (1Y)

Largest decline over 1 year

-10.78%

0.00%

-10.78%

Max Drawdown (3Y)

Largest decline over 3 years

-18.14%

Max Drawdown (5Y)

Largest decline over 5 years

-18.14%

Max Drawdown (10Y)

Largest decline over 10 years

-27.35%

Current Drawdown

Current decline from peak

-9.27%

0.00%

-9.27%

Average Drawdown

Average peak-to-trough decline

-6.92%

0.00%

-6.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.41%

0.00%

+4.41%

Volatility

IXJ vs. GERM - Volatility Comparison

iShares Global Healthcare ETF (IXJ) has a higher volatility of 3.75% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that IXJ's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IXJGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.75%

0.00%

+3.75%

Volatility (6M)

Calculated over the trailing 6-month period

10.05%

0.00%

+10.05%

Volatility (1Y)

Calculated over the trailing 1-year period

14.55%

0.00%

+14.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.21%

0.00%

+14.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

15.67%

0.00%

+15.67%

IXJ vs. GERM - Expense Ratio Comparison

IXJ has a 0.46% expense ratio, which is lower than GERM's 0.68% expense ratio.


Dividends

IXJ vs. GERM - Dividend Comparison

IXJ's dividend yield for the trailing twelve months is around 1.47%, while GERM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IXJ
iShares Global Healthcare ETF
1.47%1.40%1.50%1.38%1.17%1.12%1.27%1.42%2.11%1.46%1.73%2.85%

Frequently Asked Questions


IXJ has higher volatility (3.75%) compared to GERM (0.00%). In terms of maximum drawdown, IXJ dropped -40.60% vs GERM's 0.00%.

On 1-year performance, IXJ leads with 9.30% vs 0.00% for GERM. On fees, IXJ is cheaper at 0.46% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, IXJ has performed better with a 9.30% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IXJ is cheaper with a 0.46% expense ratio, compared with 0.68% for GERM.

IXJ has the higher dividend yield at 1.47%, compared with 0.00% for GERM.

IXJ tracks S&P Global Healthcare Sector Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: iShares and Amplify. Their fees differ too: 0.46% for IXJ and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for IXJ and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer